We have spent about Rs. 304 crore in Q2 of the current year in Capex and in the next one year's time Rs. 1,050 crore to be incurred approximately, says Nandakumar Tirumalai, Chief Financial Officer, Tata Chemicals Limited during Q2 FY23 Earnings Conference Call. 

Speaking at Q2 FY23 Earnings Conference Call, R. Mukundan, Managing Director & CEO, Tata Chemicals Limited said, "We have a 10,000 tons silica plant which is more or less fully utilized. We have a very good traction from customers especially the rubber and tyre customers for additional green tires where it's partly added to replace carbon black. We are putting up 50,000 ton in two streams of 25,000 ton each, and this Capex will be funded through internal accruals. The estimated amount is about Rs. 400 crore and it'll take about 30 months to execute. We will start the execution plan shortly and it has a good return profile including return on capital."

"As far as nutraceuticals is concerned, we are still not operating at full utilization of the 5,000-ton plant. We are going through the process of customer approval, and we should probably be getting closer by the end of this year, and we should be getting the nutraceutical plant closer to full utilisation," added Mukundan.

Tata Chemicals Limited is a leading supplier of choice to glass, detergent, industrial and chemical sectors. The company has a strong position in the crop protection business through its subsidiary company Rallis India Ltd.  and has world-class R&D facilities in Pune and Bangalore.